September 17, 2017
CASI Pharmaceuticals, Savara, Adverum Biotechnologies, ChromaDex Therapeutics and MannKind top the NASDAQ biotech stock list.
September 3, 2017
Neovasc, Adaptimmune, Curis, Vericel and MannKind top the NASDAQ biotech stock list.
August 20, 2017
Delcath Systems, MannKind, Zogenix, BioLife Solutions and BioDelivery Sciences top the NASDAQ biotech stock list.
April 27, 2017
VistaGen Therapeutics announced the publication of a nonclinical study on the effects of AV-101, the company's central nervous system disorder...